Today, he can not only stand independently but is learning to walk once more, thanks to an injection of laboratory-grown stem cells into his spinal cord. Researchers at Keio University in Tokyo ...

As expected, Concord, the Nashville-based independent music company, has added Stem Distribution to its portfolio of subsidiaries, the company announced on Monday. Terms of the deal were not discl ...

By Ethan Millman Concord has officially closed on its deal to acquire music distribution platform Stem, the companies announced Monday. The Hollywood Reporter first reported on the deal earlier in ...

A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal-cord injury. The Japanese man was one of four individuals in a first-of-its-kind trial ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SALINA, Kan. (KSNW) – A local STEM education program is getting a second chance thanks to the generosity of two community foundations. The McPherson County Community Foundation (MCCF ...

Opens in a new tab or window After HHS Secretary Robert F. Kennedy Jr. hosted a roundtable on reducing regulations on stem cells earlier this month, experts have raised concerns about a potential ...

The Ghana STEM Network suggests that the government set clear, long-term development goals for STEM education, mapping out specific plans for the next five, 10, 15, and 20 years.

Emma Morris is one of the few women in leadership positions in science, technology, engineering and maths (STEM) in Northern Ireland. According to the Department for the Economy's (DfE ...

1 Department of Critical Care Medicine, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China 2 Department of Critical Care Medicine, Affiliated Hospital of Zunyi Medical University ...

The British stem cell com­pa­ny bit.bio has re­duced its work­force by 25%, im­pact­ing most of the ther­a­peu­tics di­vi­sion, founder and board mem­ber Mark Kot­ter con­firmed … ...